Amanta Healthcare IPO Review, Analysis, Good or Bad – IPO Watch

As an investor, deciding whether or not the IPO is Good or Bad to put money into can usually be difficult. If you might be confused and fearful about whether or not to Apply or Not the Amanta Healthcare IPO. Then fear not, right here we’re describing 10 vital key factors & an in-depth, detailed Amanta Healthcare IPO assessment which is able to enable you to make the choice.

Strengths and Weaknesses of Amanta Healthcare IPO

Strengths: 

• Amanta Healthcare is a well-established producer of pharmaceutical formulations with a large product vary and presence in numerous markets.
• The firm consists of an skilled administration staff and promoters who’ve over 30 years of expertise within the pharmaceutical business. 
• The firm includes of getting a big manufacturing functionality unfold over 66,852.00 sq meters of land situated at village Hariyala, District Kheda, Gujarat, India.

Weaknesses:

• It’s all merchandise made on the manufacturing facility are situated at Hariyala village, Kheda district, Gujarat. Any delay or shutdown on the facility attributable to points like energy or water scarcity, pure catastrophe, accidents, or equipment breakdowns can badly affect the enterprise, money circulation, and monetary situation.
• The firm might not be capable to enhance its revenue margins and income sooner or later.
• In FY 2025, 45.78%, 57.25% in FY 2024, and 62.64% in FY 2023, the corporate’s finance value has been very excessive. Meaning if the corporate doesn’t scale back these prices sooner or later, then it could actually badly affect the enterprise, monetary situation, and money circulation.
• In the previous, their manufacturing license was suspended. If suspensions occur once more sooner or later can negatively affect the enterprise, money circulation, and monetary situation.

Amanta Healthcare IPO Review

• IPO Watch: May Apply
• Invest4Edu Private Limited: Apply
• Scoop Investment: May Apply
• Exencial Research Partners: May Apply
• Minerva Capital Research Solutions: May Apply
• Capital Market: Avoid

Amanta Healthcare IPO Details

Amanta Healthcare IPO Open and shutting dates?

Amanta Healthcare IPO will open for subscription on September 1, 2025, and shall be closed for subscription on September 3, 2025.

What is the dimensions of the Amanta Healthcare  IPO?

The firm deliberate to boost round ₹126 crores in funds through IPO. This IPO includes a contemporary challenge of ₹126 crores with no Offer-for-Sale element with a face worth of ₹10 every.

What are the subscription particulars of the Amanta Healthcare IPO?

The Amanta Healthcare IPO value vary is about at ₹120 to ₹126 per share. In this IPO, a complete of 119 shares had been obtainable in 1 lot dimension for the minimal Retail class. For the utmost Retail class, 1,547 shares had been obtainable in 13 lot sizes. Additionally, 1,666 shares had been obtainable in 14 lot sizes for the S-HNI Minimum class. While for the B-HNI Minimum class, 7,973 shares had been obtainable in 67 lot sizes. 

To make investments on this IPO, every investor class has particular funding quantities:

• Retail Investors: Minimum funding of ₹14,994 and most funding of ₹1,94,922.
• Small HNI (S-HNI): Minimum funding of ₹2,09,916.
• Big HSI (S-HNI): A minimal funding of ₹10,04,598 is required.

What is the Amanta Healthcare IPO itemizing Date?

Amanta Healthcare is a Mainboard IPO. Shares shall be listed on September 8, 2025, on the BSE (Bombay Stock Exchange) & NSE (National Stock Exchange).

About Amanta Healthcare

Incorporated in December 1994, Amanta Healthcare Limited is among the rising pharmaceutical corporations engaged within the growth, manufacturing, and advertising of a complete vary of sterile liquid merchandise, primarily parenterals. The firm is concerned within the making of IV fluids, diluents, eye drops, and respiratory care options. These are packed in plastic containers utilizing superior Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) applied sciences. 

As of March 31, 2025, the corporate employs a complete of 1,718 staff. Under its medical units section, Amanta Healthcare additionally presents irrigation options, first-aid gadgets, and eye lubricants. Under its personal model, the corporate makes over 45 generic merchandise and sells them in India, via 320 distributors and stockists.

What are the Objectives of the Amanta Healthcare Limited IPO?

The proceeds raised from the contemporary challenge shall be utilized to deal with the capital expenditure necessities for civil development work and in the direction of the acquisition of kit, plant, and equipment for organising a brand new manufacturing line of SteriPort at Hariyala, Kheda, Gujarat. Some proceeds shall be used in the direction of civil development work, buy of kit, plant, and equipment, and organising a brand new manufacturing line for SVP at Hariyala, Kheda, Gujarat. Lastly, the remaining funds shall be used for the corporate’s General Corporate Purposes. 

Amanta Healthcare IPO Financials

In 2024, the corporate generated a income of ₹13,946.01 crores in opposition to ₹2,690.46 crores in 2023. In 2024, reported a revenue of ₹5,245.39 crores in opposition to a revenue of ₹231.11 crores in 2023.

 Amanta Healthcare IPO Promoters

Bhavesh Patel, Vishal Patel, Jayshreeben Patel, Jitendra Kumar Patel, and Milcent Appliances Private Limited are the promoters of the corporate.

Who are the Amanta Healthcare IPO lead managers and registrar?

Beeline Capital Advisors Pvt Limited is the problem’s lead supervisor, whereas MUFG Intime India Pvt Ltd is the corporate’s registrar.

Should you apply or not for the Amanta Healthcare IPO?

Amanta Healthcare is launching an IPO that’s comprised of solely a contemporary challenge, with no offer-for-sale element. The firm has set a value band of ₹120 to ₹126 per share and a plan to boost round ₹126 crores through IPO. It is among the main pharmaceutical corporations engaged within the growth, manufacturing & advertising of a variety of Sterile Liquid merchandise. As of the DRHP submitting date, the corporate has a portfolio of 47 merchandise throughout 120 worldwide jurisdictions. 

If we speak concerning the firm’s financials, in FY25, Amanta reported an EBITDA of ₹59.7 crore, showcasing an increase of three.8% from the earlier 12 months. The proceeds raised from the contemporary challenge shall be utilized for the funding of recent manufacturing traces and different company wants. The firm incorporates applied sciences, together with ABFS and ISBM, for sterile liquid and parenteral formulations manufacturing. Expanding the National Sales community, growing enterprise from present clients, and including new clients are a few of the methods the corporate shall be following sooner or later. 

So, now the query is, must you apply or not for the Amanta Healthcare IPO? If you want to put money into an organization that promotes consumer relationships, a extremely diversified buyer base, and a confirmed observe report of constant development, Rising EBITDA and margins sign stronger working effectivity, then Amanta Healthcare’s IPO might be long-term funding choice. 

However, we advocate at all times doing monetary background verify on the corporate you wish to put money into, and investing in it at your individual danger.